Quest for the right Drug
מגנזיום סולפט קלצקס 50% MAGNESIUM SULFATE KALCEKS 50 % (MAGNESIUM SULFATE HEPTAHYDRATE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
תוך-שרירי, תוך-ורידי : I.M, I.V
צורת מינון:
אין פרטים : SOLUTION FOR INJECTION / CONCENTRATE FOR SOLUTION FOR INJ/INF
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects The frequency of undesirable effects is not known. Immune system disorder: Hypersensitivity reactions. Excessive administration of magnesium leads to the development of symptoms of hypermagnesaemia which may include: Metabolism and nutrition disorders Electrolyte/fluid abnormalities (hypophosphataemia, hypertonic dehydration) There have been isolated reports of maternal and fetal hypocalcaemia with high doses of magnesium sulfate. Nervous system disorders Respiratory depression Nausea, vomiting, drowsiness and confusion Coma Slurred speech, double vision Loss of tendon reflexes due to neuromuscular blockade Cardiac disorders Cardiac arrhythmias, cardiac arrest ECG abnormal (prolonged PR, QRS and QT intervals), bradycardia Vascular disorders Flushing of the skin and hypotension due to peripheral vasodilatation Musculoskeletal and connective tissue disorders Muscle weakness General disorders and administration site conditions Thirst Especially in patients with impaired renal function, there may be sufficient accumulation of magnesium sulfate to produce toxic effects. Injection/infusion-related Too rapid administration: Vasodilatation, reduced blood pressure Local: may be irritant to veins; extravasation may cause tissue damage Intramuscular: pain, redness, swelling or warmth at the injection site, drainage at the injection site, prolonged bleeding, cellulitis, sterile abscess, signs of an allergic reaction, such as difficulty breathing or facial swelling, injury to nearby structures (blood vessels, bones, or nerves), inadvertent intravascular or intra-ostial injection, tissue necrosis, poor absorption due to high injection volume. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לרופא
15.12.21 - עלון לרופאעלון מידע לצרכן
לתרופה במאגר משרד הבריאות
מגנזיום סולפט קלצקס 50%